SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Wall Street Analysts -- Ignore unavailable to you. Want to Upgrade?

To: Patsy Collins who wrote (47)10/26/2001 10:46:01 AM
From: Patsy Collins  Respond to of 167
 
Chris Stix at Morgan Stanley downgraded BRCD today, on his report; he has $27 on as the price. His target now $25

THe stock opened today at 25.78. This is where we'll start tracking his recommendation.

Remember that Stix did not recommend buying BRCD when it was below $14 in early October, 2001.



To: Patsy Collins who wrote (47)11/19/2001 9:43:22 PM
From: Marty Rubin  Read Replies (1) | Respond to of 167
 
They have been wrong on GYMB over and over again.

Here's a pick: Merrill downgraded RAD a few weeks back because of CVS's problems. I think Rite Aid can be fixed from within, and have already written off assets (partially to improve other quarters, I assume). We'll know the first 10 days of next year (#s are out).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News